Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02404324
Other study ID # Treatment of Esotropia
Secondary ID
Status Active, not recruiting
Phase N/A
First received December 23, 2014
Last updated April 9, 2017
Start date January 2012
Est. completion date November 2017

Study information

Verified date March 2015
Source National Centre of Ophthalmology named after academician Zarifa Aliyeva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this prospective study is the treatment of esotropia by prescribing the full precise optical correction of refractive errors in children up to 3 years old.


Description:

This investigation includes children with esotropia associated with hyperopia, hypermetropic astigmatism, myopia, myopic astigmatism and minor ametropias. All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dpt to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization were administered to the children. The investigators suggest that this approach will give good results in the treatment of esotropia.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 150
Est. completion date November 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 3 Months to 3 Years
Eligibility Inclusion Criteria:

- Within the age of 3 months to 3 years (inclusive infantile esotropia)

- Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test

- Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr)

Exclusion Criteria:

- Age above 3 years

- Patients with neurological diseases and paralytic strabismus

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Prescription of spectacles
All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Centre of Ophthalmology named after academician Zarifa Aliyeva

Outcome

Type Measure Description Time frame Safety issue
Primary The angle of deviation The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment. 2 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05527015 - Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near Phase 3
Completed NCT00746304 - Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin N/A
Completed NCT01460355 - Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone Phase 4
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Completed NCT02570555 - Strabismus Surgery and Driving Ability
Active, not recruiting NCT00993174 - Surgery for Esotropia Under Topical Anesthesia N/A
Completed NCT01166503 - Early Versus Delayed Surgery for Infantile Esotropia
Completed NCT00000121 - The Prism Adaptation Study (PAS) Phase 3
Completed NCT04429659 - Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia
Recruiting NCT05615519 - Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
Completed NCT00000163 - Congenital Esotropia Observational Study (CEOS) N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3